Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ANIP stock price vs BN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BN's multiple
Needs BN P/E.
Implied fair value · at ANIP's multiple
Needs ANIP P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ANIP FY 2025 (ended Dec 31, 2025) · BN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
ANI PHARMACEUTICALS, INC · implied price per share
Bear
$63.42
Base
$74.61
Bull
$85.80
BROOKFIELD CORPORATION · implied price per share
Bear
-$79.54
Base
-$93.58
Bull
-$107.62
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.57x
—
Net debt / EBITDA
Leverage against operating earnings
0.11x
22.21x
Cash and equivalents
Liquid reserves on the balance sheet
$285.59M
$16.24B
Total debt
Interest-bearing obligations outstanding
$309.11M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ANIP vs SUPN
PERRIGO Co plc
ANIP vs PRGO
Viatris Inc
ANIP vs VTRS
Organon & Co.
ANIP vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
ANIP vs TEVA
BXP, Inc.
ANIP vs BXP
SL GREEN REALTY CORP
ANIP vs SLG
HIGHWOODS PROPERTIES, INC.
ANIP vs HIW
CBRE GROUP, INC.
ANIP vs CBRE
JONES LANG LASALLE INC
ANIP vs JLL
KILROY REALTY CORP
ANIP vs KRC
$325.77B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
